Diabetes mellitus after renal transplantation under FK 506 (Tacrolimus) as primary immunosuppression

Transplantation Proceedings

Volumn 28, Issue 3, 1996, Pages 1304-1305

  Tanabe, K ^a   Koga, S ^a   Takahashi, K ^a   Sonda, K ^a   Tokumoto, T ^a   Babazono, T ^a   Yagisawa, T ^a   Toma, H ^a   Kawai, T ^a   Fuchinoue, S ^a   Teraoka, S ^a   Ota, K ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXYSPERGUALIN; AZATHIOPRINE; CYCLOSPORIN A; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; INSULIN; METHYLPREDNISOLONE; MIZORIBINE; OKT 3; STEROID; TACROLIMUS;

ADOLESCENT; ADULT; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONFERENCE PAPER; DIABETES MELLITUS; DIABETOGENESIS; FEMALE; HIGH RISK PATIENT; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENCE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; ORAL DRUG ADMINISTRATION; ORAL GLUCOSE TOLERANCE TEST; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUALITY OF LIFE;

ADOLESCENT; ADULT; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; METHYLPREDNISOLONE; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TACROLIMUS; TIME FACTORS;

EID: 0029994913     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)